Cost of medication is becoming a major concern even in the developed countries. This particular issue coupled with severe price competition from the generic manufacturers has prompted a number of giant multinational companies to shift or outsource their production from developed to developing and less developed countries, because of huge cost advantage. It is believed that the world pharmaceutical market will continue to see more consolidation than ever across the entire value chain of the pharmaceutical business. Big companies will continue to look for suitable partners in their supply chain management in order to reduce their cost of production.

Beximco Pharma has always operated like a 'multinational' in terms of professionalism and infrastructure so as to build the platform to become a global player. Management has adhered to international regulatory standards which is more preferable to our international partners.

Today, we have already established ourselves as a reliable partner for a number of world's leading pharmaceutical companies. These partnerships have given us expertise and know-how to contract manufacture products for reputed MNCs for the developed markets like UK, USA and Europe as soon as our new OSD plant gets certified by their respective agencies.